Cargando…

Harnessing the Immune System to Fight Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma treatment has developed enormously within the last two decades. Most recently immunotherapies have been introduced. Monoclonal antibodies targeting the plasma cell surface marker CD38, daratumumab and isatuximab, have revolutionized the standard of care treatment, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krejcik, Jakub, Barnkob, Mike Bogetofte, Nyvold, Charlotte Guldborg, Larsen, Thomas Stauffer, Barington, Torben, Abildgaard, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467095/ https://www.ncbi.nlm.nih.gov/pubmed/34572773 http://dx.doi.org/10.3390/cancers13184546

Ejemplares similares

Daratumumab for the Treatment of Multiple Myeloma
por: Plesner, Torben, et al.
Publicado: (2018)

PB2386: ASSESSMENT OF NANOPORE LONG-READ WHOLE-GENOME SEQUENCING FOR THE DETECTION OF LARGE CHROMOSOMAL STRUCTURAL VARIANTS IN MANTLE CELL LYMPHOMA
por: Hansen, Marcus, et al.
Publicado: (2023)

Reduced prevalence of SARS-CoV-2 infection in ABO blood group O
por: Barnkob, Mike Bogetofte, et al.
Publicado: (2020)

Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4
por: Valentin Hansen, Simone, et al.
Publicado: (2021)

PB2394: PTPRJ AS A ROBUST DIFFERENTIATING MARKER IN MANTLE CELL LYMPHOMA
por: Valentin Hansen, Simone, et al.
Publicado: (2023)

Replicate whole-genome next-generation sequencing data derived from Caucasian donor saliva samples
por: Hansen, Marcus Høy, et al.
Publicado: (2021)

Exploration of residual disease in stem cell products from mantle cell lymphoma using next-generation sequencing
por: Elkjær, Lea Amalia Lind, et al.
Publicado: (2022)

Therapeutics to harness the immune microenvironment in multiple myeloma
por: Ignatz-Hoover, James J., et al.
Publicado: (2022)

Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review
por: Brandt, Lærke J. B., et al.
Publicado: (2020)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma
por: Krejcik, Jakub, et al.
Publicado: (2018)

Multiple Myeloma Associated Bone Disease
por: Rasch, Stine, et al.
Publicado: (2020)

Harnessing the Immune System Against Multiple Myeloma: Challenges and Opportunities
por: Yamamoto, Leona, et al.
Publicado: (2021)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

BioReader: a text mining tool for performing classification of biomedical literature
por: Simon, Christian, et al.
Publicado: (2019)

Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*
por: Lund, Thomas, et al.
Publicado: (2010)

Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
por: Larsen, Rikke Faebo, et al.
Publicado: (2020)

The Danish National Multiple Myeloma Registry
por: Gimsing, Peter, et al.
Publicado: (2016)

Harnessing of Programmed Necrosis for Fighting against Cancers
por: Cho, Young Sik, et al.
Publicado: (2014)

Harnessing epithelial homeostatic mechanisms to fight cancer
por: Lahvic, Jamie L., et al.
Publicado: (2019)

Harnessing the power of antibodies to fight bone metastasis
por: Tian, Zeru, et al.
Publicado: (2021)

Supervised and home-based physical exercise in patients newly diagnosed with multiple myeloma—a randomized controlled feasibility study
por: Larsen, Rikke Faebo, et al.
Publicado: (2019)

Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research
por: Hansen, Marcus Celik, et al.
Publicado: (2015)

Moving ahead on harnessing synthetic lethality to fight cancer
por: Jerby-Arnon, Livnat, et al.
Publicado: (2015)

First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro
por: Lund, Thomas, et al.
Publicado: (2010)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
por: Reina-Ortiz, Chantal, et al.
Publicado: (2022)

Distal chromosome 1q aberrations and initial response to ibrutinib in central nervous system relapsed mantle cell lymphoma
por: Hansen, Marcus Høy, et al.
Publicado: (2021)

Harnessing the T Cell to Treat Multiple Myeloma: Dawn of a New Therapeutic Paradigm
por: Keller, Alana L., et al.
Publicado: (2022)

IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load
por: Hussmann, Dianna, et al.
Publicado: (2021)

Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial
por: Wickstroem, Line Adsboell, et al.
Publicado: (2021)

Antibody response following the third and fourth SARS-CoV-2 vaccine dose in individuals with common variable immunodeficiency
por: Nielsen, Bibi Uhre, et al.
Publicado: (2022)

High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action
por: Adams, Homer C., et al.
Publicado: (2018)

Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
por: Johnsen, Hans E, et al.
Publicado: (2009)

Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation
por: Andersen, Morten Nørgaard, et al.
Publicado: (2017)

Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
por: Ludwig, Heinz, et al.
Publicado: (2020)

Chemerin is elevated in multiple myeloma patients and is expressed by stromal cells and pre-adipocytes
por: Westhrin, Marita, et al.
Publicado: (2018)

The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
por: Gregersen, Henrik, et al.
Publicado: (2017)

Potential value of pre-planned imaging of bone disease in multiple myeloma
por: Gundesen, Michael T., et al.
Publicado: (2023)

Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma
por: Abildgaard, Niels, et al.
Publicado: (2023)

Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients
por: Bieghs, Liesbeth, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_797hquh0duapbfukc39p9bsnif